About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Model Key to Designing Effective Therapies for Brain Disorders Developed

by Colleen Fleiss on March 31, 2019 at 7:08 PM
Font : A-A+

New Model Key to Designing Effective Therapies for Brain Disorders Developed

Scientists have developed a novel mathematical model that could be the key to designing effective therapies for brain disorders.

The G-protein-coupled receptors are present in many neurological and psychological disorders thanks to the activation of G proteins. In addition to activating the G protein, they are also able to activate proteins responsible for other signalling routes, thereby achieving more than one effect at a time.

Advertisement


These effects can be either beneficial or detrimental and for this reason controlling them by biasing the signal into the adequate direction is a therapeutic objective. One example of this type of therapy is chronic pain and therapy with opioid drugs. Morphine releases its therapeutic effects by binding to the μ-opioid receptor and activating the signalling route of the G-proteins, but also through the same receptor it produces the adverse effects through the β-arrestin route.

A current research line found in pharmaceutical laboratories is the design of drugs which bind to the μ-opioid receptor specifically to activate the G-protein route.
Advertisement

The innovation in the design of new drugs must go hand in hand with the development of new theoretical frameworks which permit defining reliable measures for the pharmaceutical properties needing improvement.

In the study, researchers delved deeper into the quantification of the bias of the biological signal through the inclusion of the receptors' activity when not bound (constitutive activity or basal activity of the receptor). Thus, there is an increase in the pharmacological space accessible to the discovery and quantification of new drugs that are agonist, neutral antagonist and inverse antagonist (ligands which increase, do not alter or diminish the basal activities of receptors).

"Taking into account that for a specific receptor a signalling route could be linked to the therapeutic effects while another one can have adverse effects, the quantification of a biased signalling route of the receptors is fundamental for the design of more precise drugs with less side effects", says Dr Jesús Giraldo, coordinator of the study and head of the Laboratory of Molecular Neuropharmacology and Bioinformatics of the UAB Institute of Neuroscience (INc).

Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Drug News

Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Price Cap Move Will Place Eli Lilly Strongly in Insulin Market
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
Myeloma Drug: New Findings
In myeloma (blood cancer) cells, cancer-promoting potential of the fatty acid binding proteins was found to determine to be a valid target for myeloma therapeutics
Lower Dose of Acetaminophen Linked to Reduced Serious Liver Injury
Acute liver failure cases dropped after the Food and Drug Administration rule to lower the dosage of acetaminophen
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Model Key to Designing Effective Therapies for Brain Disorders Developed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests